Urogen Pharma Ltd
(URGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -65,689 | -32,286 | -102,244 | -76,228 | -54,349 |
| Depreciation Amortization | -288 | -60 | -232 | -10 | -238 |
| Accounts receivable | -1,972 | 1,285 | -2,739 | -143 | -2,801 |
| Other Working Capital | -1,444 | -4,011 | 3,336 | -4,238 | -3,183 |
| Other Operating Activity | 13,910 | 3,337 | 25,503 | 17,239 | 14,490 |
| Operating Cash Flow | $-55,483 | $-31,735 | $-76,376 | $-63,380 | $-46,081 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 25,600 | 13,518 | -759 | 10,529 | 10,028 |
| PPE Investments | -84 | N/A | -194 | -138 | -38 |
| Investing Cash Flow | $25,516 | $13,518 | $-953 | $10,391 | $9,990 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 154,807 | 54,657 | 116,931 | 116,891 | 814 |
| Other Financing Activity | 135 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $154,942 | $54,657 | $116,931 | $116,891 | $814 |
| Beginning Cash Position | 95,822 | 95,822 | 56,221 | 56,220 | 56,220 |
| End Cash Position | 220,797 | 132,262 | 95,823 | 120,122 | 20,943 |
| Net Cash Flow | $124,975 | $36,440 | $39,602 | $63,902 | $-35,277 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,483 | -31,735 | -76,376 | -63,380 | -46,081 |
| Capital Expenditure | -84 | N/A | -194 | -138 | -38 |
| Free Cash Flow | -55,567 | -31,735 | -76,570 | -63,518 | -46,119 |